Investing.com - Financial Markets Worldwide
Open in App

Sinopharm Group Co Ltd (1099)

Hong Kong
Symbol
Exchange
Currency
1099·Hong Kong·HKD
SHTDY·OTC Markets·USD
1099·Frankfurt·EUR
Currency in HKD
16.72
-0.11(-0.65%)
Delayed Data·

1099 Financial Summary

Key Ratios

P/E Ratio6.32
Price/Book0.56
Debt / Equity55.5%
Return on Equity8.11%
Dividend Yield4.63%
EBITDA19.26B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
2025
31/12
Income Statement
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa521,051.24552,147.55596,569.57584,507.93575,167.88
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa44,050.6147,434.0648,511.6844,255.3941,672.01
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa20,983.7622,764.1722,318.4917,819.0617,229.57
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa7,758.658,525.669,053.767,049.687,155.09
Balance Sheet
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa335,412.32364,775.13383,394.84392,831.24390,361.21
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa219,306.55234,962.96241,490.64250,375.59246,725.58
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa99,653.94110,069.19120,318.75126,687.3134,159.74
Cash Flow
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa-2,358.215,174.4310,158.45-6,916.652,775.2
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa9,308.0920,963.7917,173.0311,546.0214,138.21
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-1,266.96-3,589.62-944.54-3,750.93-963.89
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-14,693.01-5,693.48-7,643.97-17,285.03-18,686.65
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-6,648.8411,692.28,586.91-9,495.18-5,517.23
* In Millions of CNY (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.27%
Dividend Yield
4.69%
Industry Median 2.70%
Annualized payout
0.79
Paid annually
5-Years Growth
-
Growth Streak
Unlock

Analyst Ratings

10 Buy
4 Hold
0 Sell
Ratings:
14 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 22.82
(+36.49% Upside)

Earnings

Latest Release
Apr 23, 2026
EPS / Forecast
0.45 / --
Revenue / Forecast
140.77B / --
EPS Revisions
a
a
Unlock
Last 90 days

FAQ

What were Sinopharm Group Co's earnings for the latest quarter?

The Sinopharm Group Co EPS (TTM) is 2.27. Sinopharm Group Co reported sales of 140,765.80, net income of 1,413.94, and EPS of 0.45 for the latest quarter.

What was Sinopharm Group Co's net income for the latest quarter?

Sinopharm Group Co's net income for the latest quarter was 1,413.94.

How did Sinopharm Group Co's performance compare year-over-year in the latest quarter?

The company's revenue moved from 143,689.20 million CNY in the previous quarter to 140,765.80 million CNY in the latest quarter, and net income moved from 1,848.34 million CNY to 1,413.94 million CNY compared to the previous quarter.

What is Sinopharm Group Co's net profit margin on a TTM basis?

Sinopharm Group Co's trailing twelve months (TTM) net profit margin is 1.24%.

How does Sinopharm Group Co's debt to equity ratio compare to industry standards?

Sinopharm Group Co's total debt-to-equity ratio is 55.50%.

What is Sinopharm Group Co's return on investment on a TTM basis?

Sinopharm Group Co's trailing twelve months (TTM) return on investment (ROI) is 8.11%.

How has Sinopharm Group Co's total revenue grown this year?

Sinopharm Group Co's total revenue was 143,689.20 million CNY in the previous quarter and 140,765.80 million CNY in the latest quarter.

What is Sinopharm Group Co's gross margin on a TTM basis?

Sinopharm Group Co's trailing twelve months (TTM) gross margin is 7.17%%.

What was Sinopharm Group Co's revenue per share for the latest quarter?

Sinopharm Group Co's revenue per share for the latest quarter was 5.80.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.